Implementation of Networked Continuous Glucose Monitoring With Telemetry Within the Intensive Care Unit (ICU-TeleCGM)

ConditionsType 1 Diabetes Type 2 Diabetes Treated With Insulin Hyperglycemia Intensive Care (ICU)Continuous Glucose Monitoring Hypoglycaemia

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorImperial College Healthcare NHS Trust

About this trial

The aim of this observational study is to assess safety and implementation of continuous glucose monitors within the Intensive Care Unit. The Dexcom G7 is a continuous glucose monitoring system that shows blood glucose values in real-time and includes alarms if the glucose is very low or high.

Eligibility criteria

Qualifiers

Age >18years inclusive

Hyperglycaemia requiring insulin therapy (subcutaneous injection or intravenous insulin) during admission on ICU

Admission to ICU within 48hours

Disqualifiers

Known significant allergy to tape/ adhesives

Imminent death or anticipated length of stay <24hours

Women who are pregnant

Imminent extracorporeal membrane oxygenation (ECMO)

Trial design

Treatments tested in this trial

Dexcom G7
ViewsEMR telemetry

Treatment groups

70 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Imperial College Healthcare NHS Trust

Lead sponsor

Source ClinicalTrials.gov